179 related articles for article (PubMed ID: 38829178)
1. Extracellular vesicle proteins as breast cancer biomarkers: Mass spectrometry-based analysis.
Bandu R; Oh JW; Kim KP
Proteomics; 2024 Jun; 24(11):e2300062. PubMed ID: 38829178
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology.
Bandu R; Oh JW; Kim KP
Exp Mol Med; 2019 Mar; 51(3):1-10. PubMed ID: 30872566
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism.
Gelsomino L; Barone I; Caruso A; Giordano F; Brindisi M; Morello G; Accattatis FM; Panza S; Cappello AR; Bonofiglio D; Andò S; Catalano S; Giordano C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361728
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling in extracellular vesicles for cancer detection and monitoring.
Xue VW; Yang C; Wong SCC; Cho WCS
Proteomics; 2021 Jul; 21(13-14):e2000094. PubMed ID: 33665903
[TBL] [Abstract][Full Text] [Related]
5. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics.
Kreimer S; Belov AM; Ghiran I; Murthy SK; Frank DA; Ivanov AR
J Proteome Res; 2015 Jun; 14(6):2367-84. PubMed ID: 25927954
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Derived Extracellular Vesicles as a Novel Source of Protein Biomarkers for Cancer Diagnosis and Monitoring.
Ruhen O; Meehan K
Proteomics; 2019 Jan; 19(1-2):e1800155. PubMed ID: 30467990
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from young women's breast cancer patients drive increased invasion of non-malignant cells via the Focal Adhesion Kinase pathway: a proteomic approach.
Jordan KR; Hall JK; Schedin T; Borakove M; Xian JJ; Dzieciatkowska M; Lyons TR; Schedin P; Hansen KC; Borges VF
Breast Cancer Res; 2020 Nov; 22(1):128. PubMed ID: 33225939
[TBL] [Abstract][Full Text] [Related]
8. Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform.
Rai A; Fang H; Claridge B; Simpson RJ; Greening DW
J Extracell Vesicles; 2021 Nov; 10(13):e12164. PubMed ID: 34817906
[TBL] [Abstract][Full Text] [Related]
9. The role and potential application of extracellular vesicles in liver cancer.
Qi X; Chen S; He H; Wen W; Wang H
Sci China Life Sci; 2021 Aug; 64(8):1281-1294. PubMed ID: 33847910
[TBL] [Abstract][Full Text] [Related]
10. Early Cancer Biomarker Discovery Using DIA-MS Proteomic Analysis of EVs from Peripheral Blood.
Espejo C; Lyons B; Woods GM; Wilson R
Methods Mol Biol; 2023; 2628():127-152. PubMed ID: 36781783
[TBL] [Abstract][Full Text] [Related]
11. Ciliary extracellular vesicles are distinct from the cytosolic extracellular vesicles.
Mohieldin AM; Pala R; Beuttler R; Moresco JJ; Yates JR; Nauli SM
J Extracell Vesicles; 2021 Apr; 10(6):e12086. PubMed ID: 33936569
[TBL] [Abstract][Full Text] [Related]
12. Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.
Drucker A; Yoo BH; Khan IA; Choi D; Montermini L; Liu X; Jovanovic S; Younis T; Rosen KV
Breast Cancer Res; 2020 Oct; 22(1):105. PubMed ID: 33023655
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles.
Munshi A; Mehic J; Creskey M; Gobin J; Gao J; Rigg E; Muradia G; Luebbert CC; Westwood C; Stalker A; Allan DS; Johnston MJW; Cyr T; Rosu-Myles M; Lavoie JR
Stem Cell Res Ther; 2019 Dec; 10(1):401. PubMed ID: 31852509
[TBL] [Abstract][Full Text] [Related]
14. Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi-omic analysis.
Lane RE; Korbie D; Khanna KK; Mohamed A; Hill MM; Trau M
Proteomics; 2024 Jun; 24(11):e2300089. PubMed ID: 38168906
[TBL] [Abstract][Full Text] [Related]
15. Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis.
Lee Y; Ni J; Beretov J; Wasinger VC; Graham P; Li Y
Mol Cancer; 2023 Feb; 22(1):33. PubMed ID: 36797736
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer.
Sadovska L; Eglītis J; Linē A
Anticancer Res; 2015 Dec; 35(12):6379-90. PubMed ID: 26637847
[TBL] [Abstract][Full Text] [Related]
17. Protein Composition Reflects Extracellular Vesicle Heterogeneity.
Vagner T; Chin A; Mariscal J; Bannykh S; Engman DM; Di Vizio D
Proteomics; 2019 Apr; 19(8):e1800167. PubMed ID: 30793499
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping.
Rontogianni S; Synadaki E; Li B; Liefaard MC; Lips EH; Wesseling J; Wu W; Altelaar M
Commun Biol; 2019; 2():325. PubMed ID: 31508500
[TBL] [Abstract][Full Text] [Related]
19. Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location.
Zhong ME; Chen Y; Xiao Y; Xu L; Zhang G; Lu J; Qiu H; Ge W; Wu B
EBioMedicine; 2019 Dec; 50():211-223. PubMed ID: 31753726
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
